LXRs激动剂T0901317对成人和SD大鼠骨骼肌细胞FAT/CD36基因mRNA表达的作用及FAT/CD36基因多态性与2型糖尿病关系
|
摘要
目的研究骨骼肌卫星细胞体外纯化、培养、鉴定的方法及其生物学特性。方法采用Ⅰ型胶原酶和胰蛋白酶两步消化法纯化出成人骨骼肌卫星细胞和大鼠骨骼肌卫星细胞,进行体外原代和传代培养,借此观察卫星细胞的增殖、分化特点并进行免疫细胞化学染色鉴定。结果两步消化法是获取卫星细胞可靠的方法。生长培养基促使细胞的增殖;延迟分瓶或分化培养基促使细胞分化形成骨骼肌细胞并最终融合形成肌管。骨骼肌结蛋白(desmin)单克隆抗体免疫细胞化学染色法是鉴定骨骼肌细胞的可靠方法。SD大鼠骨骼肌细胞生长曲线的每个时期较成人骨骼肌细胞的相应时期都缩短1-2天。结论体外培养的成人骨骼肌卫星细胞和大鼠骨骼肌卫星细胞在合适的培养条件和传代比例下能够增殖与分化并保持其生物学特性,为其在后续研究中的应用奠定了基础。
目的探讨肝核受体LXRs激动剂T0901317对正常人骨骼肌细胞中FAT/CD36基因mRNA表达的影响。方法将原代培养的5例成人骨骼肌细胞分为用肝核受体LXRs激动剂T0901317(1μmol/L)作用组、T0901317(0.5μmol/L)作用组和未作用(阴性对照)组,采用SYBR GreenⅠ实时荧光定量PCR法检测各组成人骨骼肌细胞FAT/CD36基因mRNA表达水平,并进行比较分析。结果(1)以浓度为1μmol/L的T0901317作用组和0.5μmol/L的T090131作用组和未作用组样本的均数进行方差分析,差别有统计学意义(P＜0.05)。(2)进一步用2~(-ΔΔCt)公式法进行mRNA表达的倍数分析,浓度为1μmol/L的T0901317作用组和0.5μmol/L的T090131作用组成人骨骼肌细胞中FAT/CD36基因的mRNA表达分别是未作用组的3.03倍和2.91倍。结论肝核受体LXRs激动剂T0901317能够提高成人骨骼肌细胞中FAT/CD36基因mRNA的表达水平,提示T0901317可以加快骨骼肌细胞内脂肪酸的堆积,推测LXRs激动剂T0901317可能有增加糖尿病患者骨骼肌胰岛素抵抗的风险。
目的探讨肝核受体LXRs激动剂T0901317对正常SD大鼠骨骼肌细胞中FAT/CD36基因mRNA表达的影响。方法将原代培养的5例SD大鼠骨骼肌细胞分为用肝核受体LXRs激动剂T0901317(1μmol/L)作用组、T0901317(0.5μmol/L)作用组和未作用(阴性对照)组,采用SYBR GreenⅠ实时荧光定量PCR法检测各组SD大鼠骨骼肌细胞FAT/CD36基因mRNA表达水平,并进行比较分析。结果肝核受体激动剂T0901317(1μmol/L)作用组与T0901317(0.5μmol/L)作用组和阴性对照组的Ct值样本均数进行方差分析,显示T0901317(1μmol/L)作用组和T0901317(0.5μmol/L)作用组与阴性对照组相比,差异没有统计学意义(P=0.116),提示肝核受体LXRs的激动剂T0901317对于FAT/CD36基因mRNA在正常SD大鼠骨骼肌细胞中的表达没有明显作用。结论肝核受体LXRs激动剂T0901317对SD大鼠骨骼肌细胞中FAT/CD36基因mRNA的表达水平没有明显作用,提示T0901317在促进SD大鼠骨骼肌细胞内脂肪酸的堆积作用尚无确切的证据。
目的探讨FAT/CD36脂肪酸转位酶基因启动子区-3489C/T和密码子区478C/T多态性与2型糖尿病(T2DM)的相关性。方法运用聚合酶链反应-限制性片段长度多态性技术对196例2型DM患者和120例正常对照者的-3489C/T与478C/T多态性进行检测,并比较各组间基因型频率和等位基因频率以及相关临床资料。结果(1)所有研究对象均无一例存在FAT/CD36基因启动子区478C→T突变,基因型均表现为478CC之纯合子,478CC和478TT等位基因频率分别为1和0。(2)T2DM组和正常对照组的-3489C/T多态性基因型和等位基因频率比较无显著性差异,P值分别为0.682和0.683。结论中国云南昆明地区的汉族人中FAT/CD36基因的启动子区-3489C/T和密码子区478 C/T多态性与昆明地区汉族人群2型糖尿病的发生无显著相关关系。
Objective To establish the methods for purification,culture, identification and biological characteristics of adult human and rat skeletal muscle satellite cells(SCs).Methods Human skeletal muscle cell and SD rat skeletal muscle cell were obtained by the two-steps method of collegenase-1 and trypsin,and were subjected to primary as well as secondary culture in vitro.Morphological characteristics,myotube formation and growth curve were observed to evaluate the proliferative and differentiation ability of SCs.The SCs were identified with cellular immuno-chemical stain.Results The two-steps method with collegenase-l and trypsin was reliable for collection of SCs.The cells showed high proliferative ability in the proliferative media and could form myotubes in differentiation media.The satellite cells of adult rat and human can be proliferated and differentiated in different serum concent ration,and can be identified by desmin stain.The growth periods in growth curve of rat was shorter than that of aldult human.Conclusion The SCs cultured in vitro from rat skeletal muscle or human skeletal muscle have high proliferative and differentiation ability and maintain their biological characteristics.They can be used to the continual study.
Objective To investigate the Liver X receptors agonists T0901317's effection on expression of FAT/CD36 gene mRNA in aldult human skeletal muscle cell.Methods Myotubes from humans were exposed to different T0901317 concentrations(0,0.5,and 1.0μmol/l)for 24 hours before experiments were performed.Then the expression of FAT/CD36 mRNA in skeletal muscle cell of each experimental human group was detected by SYBR Green I real-time quantitative polymerase chain reaction.The relative data were compared among groups by 2~(-△△Ct)method.Results(1)The Ct mean of control group,T0901317(0.5μmol/l)group,T0901317(1μmol/l)group was analyzed and the difference has significance(P＜0.05).(2)The expression of FAT/CD36 mRNA with Liver X receptors agonists T0901317 in human skeletal muscle cell in the T0901317(0.5μmol/l)group and T0901317(1μmol/l)group was 2.91 times and 3.03 times than the control group.Conclusion The expression of FAT/CD36 mRNA in human skeletal muscle cell afer the treatment of Liver X receptors agonists T0901317 was increasing and the fatty acid in human skeletal muscle cell increased,so we may propose that T0901317 may increase the risk of resistance in aldult human skeletal muscle.
Objective To investigate the Liver X receptors agonists T0901317's effection on expression of FAT/CD36 gene mRNA in SD rat skeletal muscle cell.Metbods Myotubes from SD rats were exposed to different T0901317 concentrations(0,0.5,and 1.0μmol/l)for 24 hours before experiments were performed.Then the expression of FAT/CD36 gene mRNA in skeletal muscle cell of each experimental human group was detected by SYBR Green I real-time quantitative polymerase chain reaction.The relative data were compared among groups by 2~(-△△Ct)method.Results The Ct mean of control group,T0901317(0.5βmol/l)group,T0901317(1μmol/l)group was analyzed and the difference has no significance in the three groups.Conclusion The expression of FAT/CD36 gene in SD rat skeletal muscle cell after the treatment of Liver X receptors agonists T0901317 was the same as control group,so we propose that T0901317 may not increase the risk of skeletal muscle resistance of SD rats.
Objective To study the correlation between fatty acid translocase (FAT/CD36)gene promoter region -3489C/T and code region 478C/T polymorphism and type 2 diabetes mellitus.Methods -3489C/T and 478C/T polymorphism were screened in 196 type 2 diabetic patients and 119 controls by polymerase chain reaction restriction fragment lenth polymorphism method(PCR-RFLP).Results(1)All subjects proved to be homozygote wildtypes(CC)for the 478C→T substitution.(2)No significant differences were found in alleles and genotype frequencies of FAT/CD36 gene -3489C/T polymorphism between diabetic patients and non-diabetic contronl.Conclusion FAT/CD36 gene -3489C/T or 478C/T polymprphism was not significantly associated with type 2 diabetes mellitus in Han people of Yunnan.
目的探讨肝核受体LXRs激动剂T0901317对正常人骨骼肌细胞中FAT/CD36基因mRNA表达的影响。方法将原代培养的5例成人骨骼肌细胞分为用肝核受体LXRs激动剂T0901317(1μmol/L)作用组、T0901317(0.5μmol/L)作用组和未作用(阴性对照)组,采用SYBR GreenⅠ实时荧光定量PCR法检测各组成人骨骼肌细胞FAT/CD36基因mRNA表达水平,并进行比较分析。结果(1)以浓度为1μmol/L的T0901317作用组和0.5μmol/L的T090131作用组和未作用组样本的均数进行方差分析,差别有统计学意义(P＜0.05)。(2)进一步用2~(-ΔΔCt)公式法进行mRNA表达的倍数分析,浓度为1μmol/L的T0901317作用组和0.5μmol/L的T090131作用组成人骨骼肌细胞中FAT/CD36基因的mRNA表达分别是未作用组的3.03倍和2.91倍。结论肝核受体LXRs激动剂T0901317能够提高成人骨骼肌细胞中FAT/CD36基因mRNA的表达水平,提示T0901317可以加快骨骼肌细胞内脂肪酸的堆积,推测LXRs激动剂T0901317可能有增加糖尿病患者骨骼肌胰岛素抵抗的风险。
目的探讨肝核受体LXRs激动剂T0901317对正常SD大鼠骨骼肌细胞中FAT/CD36基因mRNA表达的影响。方法将原代培养的5例SD大鼠骨骼肌细胞分为用肝核受体LXRs激动剂T0901317(1μmol/L)作用组、T0901317(0.5μmol/L)作用组和未作用(阴性对照)组,采用SYBR GreenⅠ实时荧光定量PCR法检测各组SD大鼠骨骼肌细胞FAT/CD36基因mRNA表达水平,并进行比较分析。结果肝核受体激动剂T0901317(1μmol/L)作用组与T0901317(0.5μmol/L)作用组和阴性对照组的Ct值样本均数进行方差分析,显示T0901317(1μmol/L)作用组和T0901317(0.5μmol/L)作用组与阴性对照组相比,差异没有统计学意义(P=0.116),提示肝核受体LXRs的激动剂T0901317对于FAT/CD36基因mRNA在正常SD大鼠骨骼肌细胞中的表达没有明显作用。结论肝核受体LXRs激动剂T0901317对SD大鼠骨骼肌细胞中FAT/CD36基因mRNA的表达水平没有明显作用,提示T0901317在促进SD大鼠骨骼肌细胞内脂肪酸的堆积作用尚无确切的证据。
目的探讨FAT/CD36脂肪酸转位酶基因启动子区-3489C/T和密码子区478C/T多态性与2型糖尿病(T2DM)的相关性。方法运用聚合酶链反应-限制性片段长度多态性技术对196例2型DM患者和120例正常对照者的-3489C/T与478C/T多态性进行检测,并比较各组间基因型频率和等位基因频率以及相关临床资料。结果(1)所有研究对象均无一例存在FAT/CD36基因启动子区478C→T突变,基因型均表现为478CC之纯合子,478CC和478TT等位基因频率分别为1和0。(2)T2DM组和正常对照组的-3489C/T多态性基因型和等位基因频率比较无显著性差异,P值分别为0.682和0.683。结论中国云南昆明地区的汉族人中FAT/CD36基因的启动子区-3489C/T和密码子区478 C/T多态性与昆明地区汉族人群2型糖尿病的发生无显著相关关系。
Objective To establish the methods for purification,culture, identification and biological characteristics of adult human and rat skeletal muscle satellite cells(SCs).Methods Human skeletal muscle cell and SD rat skeletal muscle cell were obtained by the two-steps method of collegenase-1 and trypsin,and were subjected to primary as well as secondary culture in vitro.Morphological characteristics,myotube formation and growth curve were observed to evaluate the proliferative and differentiation ability of SCs.The SCs were identified with cellular immuno-chemical stain.Results The two-steps method with collegenase-l and trypsin was reliable for collection of SCs.The cells showed high proliferative ability in the proliferative media and could form myotubes in differentiation media.The satellite cells of adult rat and human can be proliferated and differentiated in different serum concent ration,and can be identified by desmin stain.The growth periods in growth curve of rat was shorter than that of aldult human.Conclusion The SCs cultured in vitro from rat skeletal muscle or human skeletal muscle have high proliferative and differentiation ability and maintain their biological characteristics.They can be used to the continual study.
Objective To investigate the Liver X receptors agonists T0901317's effection on expression of FAT/CD36 gene mRNA in aldult human skeletal muscle cell.Methods Myotubes from humans were exposed to different T0901317 concentrations(0,0.5,and 1.0μmol/l)for 24 hours before experiments were performed.Then the expression of FAT/CD36 mRNA in skeletal muscle cell of each experimental human group was detected by SYBR Green I real-time quantitative polymerase chain reaction.The relative data were compared among groups by 2~(-△△Ct)method.Results(1)The Ct mean of control group,T0901317(0.5μmol/l)group,T0901317(1μmol/l)group was analyzed and the difference has significance(P＜0.05).(2)The expression of FAT/CD36 mRNA with Liver X receptors agonists T0901317 in human skeletal muscle cell in the T0901317(0.5μmol/l)group and T0901317(1μmol/l)group was 2.91 times and 3.03 times than the control group.Conclusion The expression of FAT/CD36 mRNA in human skeletal muscle cell afer the treatment of Liver X receptors agonists T0901317 was increasing and the fatty acid in human skeletal muscle cell increased,so we may propose that T0901317 may increase the risk of resistance in aldult human skeletal muscle.
Objective To investigate the Liver X receptors agonists T0901317's effection on expression of FAT/CD36 gene mRNA in SD rat skeletal muscle cell.Metbods Myotubes from SD rats were exposed to different T0901317 concentrations(0,0.5,and 1.0μmol/l)for 24 hours before experiments were performed.Then the expression of FAT/CD36 gene mRNA in skeletal muscle cell of each experimental human group was detected by SYBR Green I real-time quantitative polymerase chain reaction.The relative data were compared among groups by 2~(-△△Ct)method.Results The Ct mean of control group,T0901317(0.5βmol/l)group,T0901317(1μmol/l)group was analyzed and the difference has no significance in the three groups.Conclusion The expression of FAT/CD36 gene in SD rat skeletal muscle cell after the treatment of Liver X receptors agonists T0901317 was the same as control group,so we propose that T0901317 may not increase the risk of skeletal muscle resistance of SD rats.
Objective To study the correlation between fatty acid translocase (FAT/CD36)gene promoter region -3489C/T and code region 478C/T polymorphism and type 2 diabetes mellitus.Methods -3489C/T and 478C/T polymorphism were screened in 196 type 2 diabetic patients and 119 controls by polymerase chain reaction restriction fragment lenth polymorphism method(PCR-RFLP).Results(1)All subjects proved to be homozygote wildtypes(CC)for the 478C→T substitution.(2)No significant differences were found in alleles and genotype frequencies of FAT/CD36 gene -3489C/T polymorphism between diabetic patients and non-diabetic contronl.Conclusion FAT/CD36 gene -3489C/T or 478C/T polymprphism was not significantly associated with type 2 diabetes mellitus in Han people of Yunnan.
引文
[1]Zierath J R,Houseknecht K,Gnudi L,et al.High fat feeding impairs insulin stimulated GLUT4 recruitment in muscle via an early insulin signaling defect[J]Diabetes,1997,46:215-223.
[2]Mauro A.Satellite cells of skeletal muscle fibers[J].J Biophys Biochem Cytol,1961,9:493-495.
[3]Gibson MC,Schultz E.Age2related differences in absolute numbers of skeletal muscle satellite cell s[J].Muscle Nerve,1983,6(8):574-580.
[4]吕捷,赵春礼,鲁强,等.成年动物骨骼肌细胞原代培养及转染外源基因的初步研究[J].解剖学报,2000,31(1):87-89.
[5]Allen RE,Temm - Grove CJ,Sheehan SM,et al.Skeletal muscle satellite cell cultures[J].Methods Cell Bio,1997,52:155-176.
[6]周菲,秦永文,荆清,等.成年大鼠肌卫星细胞的原代培养[J]。中华老年心脑血管病杂志,2001,3(1):344-346.
[7]Bonavaud S,Agbulut O,D'Honneur G,et al.Preparation of isolated human muscle fibers:a technical report[J].In Vitro Cell Dev Biol Anim,2002,38(2):66-72.
[8]黄汉伟,徐建光,顾玉东,等.人体肌卫星细胞培养的实验研究[J].中国修复重建外科杂志,2001,15(5):265-268.
[9]邵素霞,张雷,赵春芳,等.新生大鼠骨骼肌卫星细胞的原代培养及标记方法[J].基础医学与临床,2004,24(1):79-82.
[11]李志华,宋锦,李小玉,等.SD大鼠乳鼠咀嚼肌肌卫星细胞的原代培养[J].江西医学院学报,2005,45(1):17-19.
[10]陈岩,王琨,朱大海.鸡骨骼肌卫星细胞的分离培养、鉴定及生物学特性研究[J],遗传,2006,28(3):257-260.
[12]杨成、周树夏.肌肉组织工程的基础研究-不同培养条件对卫星细胞增殖的影响[J].中国美容医学,2004,13(2),135-137.
[13]魏宽海,裴国献,史宇恒,等.骨骼肌卫星细胞的培养鉴定及生物学特性[J].中国危重病急救医学,2002,14(2):10.
[1]Kenneth J,Livak,Thomas D,Schmittgen,et al.Analysis of relative gene expression data using real-time quantitative PCR and the 2~(-△△Ct)Ct method.Methods 25,2001,402-408.
[2]HEID CA,SREVRNS J.Real time quantitative PCR[J].Genome Research,1996,6:986-994.
[3]BECKER K,PAN D,WHITELYCB.Real-time quantitative polymerase chain reaction to assess gene transfer[J].Hum Gene The,1999,10:2559-2566.
[4]Whitcombe D,Brownie J,Gillard HL,et al.A homegenenous fluorescence assay for PCR amplicons:its application to real-time,single-tube genotyping[J].Clin Chem,1998,44(4):918-923.
[5]Chiang P-W,Song W-J,Wu K-Y,et al.Use of a fluorescent PCR reaction to detect genomic sequence copy number and transcription abundance[J].Genome Res,1996,6(2):1013-1026.
[6]李秀钧.胰岛素抵抗综合征.北京:人民卫生出版社,2001,123:108-110.
[7]Stuart CA,Wen G,Williamson ME,et al.Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4:protein in muscle from patient swith acanthosis nigricans and severe insulin resistance[J].Metabolism,2001,50(7):771-777.
[8]Blaak EE,Wolffen buttel BH,Saris WH,et al.Weight reduction and the impaired plasma derived free fatty acidoxidation in type 2 diabetes[J].Clin Endocrinol Metab,2001,86(4):1638-646
[9]林媛媛,蒙碧辉.游离脂肪酸异常蓄积与骨骼肌胰岛素抵抗[J].广西医科大学学报,2006,Aug,23(4):683-685.
[10]高磊,鲍羿,洪斌.B类清道夫受体CD36的研究进展[J].医学分子生物学杂志,2006,3(1):61-64.
[11]POHL J,R INGA,EHEHALT R,et all Long2chain fatty acid up take into adipocytes depends on lip id raft function[J].Biochemistry,2004,43(14):4179-4187.
[12]Bonen A,Benton CR,Campbell SE et al.Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction,insulin and leptin,and in obesity and diabetes[J].Acta Physiol Scand,2003,178:347-356.
[13]J.J.Luiken,D.J.Dyck,X.X.Han,et al.Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane[J].Am.J.Physiol:Endocrinol.Metab,2002,282:E491-E495.
[14]Arend Bonen,Michelle L.Parolin,Gregory R.Steinberg.Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36[J].The FASEB Journal,2004,10:1065-1096.
[15]Sampson MJ,Davies IR,et al.Increased expression of a scavenger receptor CD36 in monocytes from subjects with type 2 diabetes[J].Atherosclerosis,2003,167:129-134.
[16]Michael JS,Isabel RD,Simon B,et al.Increased expression of a scavenger receptor(CD36)in monocytes from subjects with type 2 diabetes[J].Atherosclerosis,2003,167:129-134.
[17]贾维娜,宋光耀.游离脂肪酸对骨骼肌葡萄糖利用的影响[J].国外医学内科学分册,2006,33(12):532-535.
[18]杨光锐,吴静,陈丽红.代谢性核受体及其与代谢综合征的关系[J].基础医学与临床.2006,26(1):35-41.
[19]Hubertina M.lmsen,Theodore P,Ciaraldi,et al.Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J].Am J Physiol Endocrinol Metab,2003,285:E354-E362.
[20] George E. O. Muscat Brandee L. Wagner, Jinzhao Hou, et al. Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors[J]. The Journal of Biological Chemistry,2002,277:40722-40728.
[21] FEBBRA IO M, HAJJAR D P, SILVERSTEINRL. CD36: a class B scavenger recep tor involved in angiogenesis, atherosclerosis, inflammation, and lip id metabolism[J]. J Clin Invest, 2001,108 (6) : 785-791.
[22] Hubertina M.lmsen, Theodore P. Ciaraldi, Leslie Carter,et al.Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J]. Am J Physiol Endocrinol Metab,2003,285: E354-E362.
[23] CH INETTI G, LESTAVEL S, BOCHER V, et al. PPAR-alpha and PPAR2gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway[J]. NatMed, 2001,7 (1): 53-58
[24] Eili T. Kase, Andreas J. Wensaas.Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway[J]. Diabetes, 2005, 54: 1108-1115.
[25] Sean B. Joseph, Bryan A. Laffitte, Parthive H. Patel, et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors[J].The Journal of Biological Chemistry, 2002,277:11019-11025.
[1]Hironobu Makino,Hiroaki Shimizu,Hiroshi Ito,et al.Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy.World J Gastroenteol,2006April,7;12(13):2053-2059.
[2]Kenneth J,Livak,Thomas D,Schmittgen,et al.Analysis of relative gene expression data using real-time quantitative PCR and the 2~(-△△Ct)Ct method.Methods 25,2001,402-408.
[3]IBrahimi A,Bonen A,Blinn WD,et al.Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscles,reduces plasma triglycerides and fatty acids,and increases plasma glucose and insulin[J].Journal of Biological Chemistry,1999,274,26761-26766.
[4] Rutter GA ,Da Silva Xavier G,Leclerc I. Roles of 5'AMP-activated protein kinase in mammalian glucose homeostasis[J].BiochemJ,2003,375:1216-1219.
[5] Tsuboi T ,Da Silva Xavier G,Leclerc I ,et al. 5'2 AMP activated protein kinase controls insulin2containing secretory vesicle dynamics[J]. J Biol Chem,2003,278:52042-52051.
[6] Wu J,Zhang Y,Wang N, et al.Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells [J] .Am J Physiol Renal Physiol ,2004,287:F886-895.
[7] Da Silva Xavier QLeclerc I,Varadi A,et al.Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression[J].BiochemJ, 2003,371:761-774.
[1]E.Corpeleijn,C.J.H.van der Kallen,et al.Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance[J].2006,Diabetic Medicine,23,907-911.
[2]Tanaka T,Nakata T,et al.Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations[J].Lipid Res,2001,42:751-759.
[3]林媛媛,蒙碧辉.游离脂肪酸异常蓄积与骨骼肌胰岛素抵抗[J].广西医科大学学报,2006,23(4):683-685.
[4]贾维娜,宋光耀.游离脂肪酸对骨骼肌葡萄糖利用的影响[J].国外医学内科学分册,2006,33(12):532-535.
[5]Veronic Bezairel,Clinton R.Brucel,George J.F.Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes:essential role in fatty acid oxidation[J].PresS.Am J Physiol Endocrinol Metab,2006,290(3):E509-515.
[6]J.J.Luiken,D.J.Dyck,X.X.Han,et al.Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane[J].Am.J.Physiol:Endocrinol.Metab,2002,282:E491-E495.
[7]Hubertina M.Wilmsen,Theodore P.Ciaraldi,Leslie Carter,et al.Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J].Am J Physiol Endocrinol Metab,2003,28.5:E354-E362.
[1]高磊,鲍羿,洪斌.B类清道夫受体CD36的研究进展[J].医学分子生物学杂志,2006,3(1):61-64.
[2]Veronic Bezaire1,Clinton R.Bruce1,George J.F.Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes:essential role in fatty acid oxidation[J].PresS.Am J Physiol Endocrinol Metab,2006,290(3):E509-15.
[3]G.Campbell,S.E.Gordon,C.L.Carlson.et al..Differential global gene expression in red and white skeletal muscle[J].Am J Physiol Cell Physiol,2001,280:C763-C768.
[4]IBrahimi A,Bonen A,Blinn WD,et al.Muscle-specific overexpression of FAT/CD36enhances fatty acid oxidation by contracting muscles,reduces plasma triglycerides and fatty acids,and increases plasma glucose and insulin[J].Journal of Biological Chemistry,1999,274,26761-26766.
[5]Bonen,A.,Luiken,J.J.,Arumugam,Y.,et al.Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase[J].Biol.Chem,2000,275,14501-14508.
[6]Palanivel R and Sweeney G.Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin[J].FEBS Lett,2005,579:5049-5054.
[7]Turcotte LP,Raney MA and Todd MK.ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle[J].Acta Physiol Scand,2005,184:131-139.
[8]J.J.Luiken,D.J.Dyck,X.X.Han,et al.Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane[J].Am.J.Physiol:Endocrinol.Metab,2002,282:E491-E495.
[9]Arend Bonen,Michelle L.Parolin,Gregory R.Steinberg.Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36[J]. The FASEB Journal,2004,10: 1065-1096.
[10] Hubertina M.lmsen, Theodore P. Ciaraldi, Leslie Carter,et al.Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J]. Am J Physiol Endocrinol Metab,2003,285: E354-E362.
[11] B. Cheatham, C.R. Kahn. Insulin action and the insulin signaling network[J].Endocr. Rev, 1995,16:117-142.
[12] Steinberg, G. R., and Dyck, D. J. Development of leptin resistance in rat soleus muscle in response to high-fat diets[J]Am. J. Physiol,2000,279: E1374-E1382.
[13] Gregory R. Steinberg, David J. Dyck, Jorges Calles-Escandon.Chronic Leptin Administration Decreases Fatty Acid Uptake and Fatty Acid Transporters in Rat Skeletal Muscle[J]. The journal of biological chemistry,2002,277 (11) .8854-8860.
[14] Pohl, J., A. Ring, and W. Stremmel. Uptake of long-chain fatty acids in HepG2 cells involves caveolae: analysis of a novel pathway[J]. Lipid Res,2002,43:1390-1399.
[15] Bodil Vistisen, Kirstine Roepstorff, Carsten Roepstorff.Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers[J]. Journal of Lipid Research,2004,45:603-609.
[16] Veronic Bezaire, Clinton R. Bruce, George J. F. Heigenhauser, Narendra N. Tandon. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes:essential role in fatty acid oxidation[J]. Am J Physiol Endocrinol Metab.2006,290: E509-E515.
[17] Shannon E. Campbell, Narendra N. Tandon, Gebretateos Woldegiorgis.A novel function for fatty acid translocase (FAT)/CD36 Involvement in long chain fatty acid transfer into the mitochondria[J]. The journal of biological chemistry,2004,279 (35) :36235-36241.
[1]朱锋,李红.LXRs与糖尿病[J].国际内分泌代谢杂志,2006,26:43-53.
[2]George E.O.Muscat Brandee L.Wagner,Jinzhao Hou,et al.Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors[J].The Journal of Biological Chemistry,2002,277:40722-40728.
[3]杨光锐,吴静,陈丽红,管又飞.代谢性核受体及其与代谢综合征的关系[J].基础医学与临床,2006,26:35-37.
[4]Horton,J.D.,J.L.Goldstein,and M.S.Brown.SREBPs:activators of the complete program of cholesterol and fatty acid synthesis in the liver[J].J.Clin.Invest,2002,109:1125-1131.
[5]Schultz JR,Tu H,Luk A,et al.Role of LXRs in control of lipogenesis[J].Genes Dev,2000,14:2831-2838.
[6]Chen,G.,G.Liang,J.Ofu,J.L.Goldstein,et al.Central role for liver X receptor in insulin-mediated activation of SREBP-1c transcription and stimulation of fatty acid synthesis in liver[J].Proc.Natl.Acad.Sci,2004,101:11245-11250.
[7]唐韬,李燕.固醇调节元件结合蛋白与脂质代谢[J].生理科学进展,2005,36:29-34.
[8]Kim,H.J.,M.Takahashi,and O.Ezaki.Fish oil feeding decreasesmature sterol regulatory element-binding protein 1(SREBP-1)by downregulationof SREBP-1c mRNA in mouse liver.A possible mechanism fordown-regulation of lipogenic enzyme mRNAs[J].Biol.Chem,1999,274:25892-25898.
[9]Eili T.Kase,Andreas J.Wensaas.Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway[J].Diabetes,2005,54:1108-1115.
[10]Ronnett.Kim EK,Landree LE Tu Y.Fatty acid metabolism as a target for obesity treatment[J].Physiol Behav,2005,85(1):25-35.
[11]Pender C,Trentadue AR,Pories WJ,et al.Expression of genes regulating Malonyl-CoA in human skeletal muscle[J].JCell Biochem,2006,99(3):860-867.
[12]Maria-Jesus Latasa,Yang Soo Moon,Kee-Hong Kim,et al.Nutritional regulation of the fatty acid synthase promoter in vivo:Sterol regulatory element binding protein functions through an upstream region containing a sterol regulatory element[J].PNAS,Sep 2000,97:10619-10623.
[13]Sean B.Joseph,Bryan A.Laffitte,Parthive H.Patel,et al.Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors[J].The Journal of Biological Chemistry,.2002,277:11019-11025.
[14]D.Cozzone.C.Debard.N.Dif.N.Ricard.E.Disse.Activation of liver X receptors promotes lipid aeeumulation but does not alter insulin action in human skeletal muscle cells[J].Diabetologia,2006,49:990-999.
[15].Luiken,J.J.,Turcotte,L.P.and Bonen,A.Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles[J].Lipid.Res,1999,40:1007-1016.
[16]Gurnell M:PPARgamma and metabolism:insights from the study of human genetic variants [J].Clin Endocrinol(Oxf),2003,59:267-277.
[17]Hulver MW,Berggren JR,Carper MJ,Miyazaki.Elevated stearoyl-CoA desaturase-l expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans[J].Cell Metab,2005,2(5):275-276.
[18] Chu K,Miyazaki M,Man WC,Ntambi JM. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation[J].Mol Cell Biol,2006,26(18):6786-6798.
[19] Dalen KT, Ulven SM, Bamberg K, et al. Expression of the insulin responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor[J]. J Biol Chem,2003, 278:48283-48291.
[20] Ducluzeau PH, Perretti N, Laville M, et al.Regulation by insulin of gene expression in human skeletal muscle and adipose tissue: evidence for specific defects in type 2 diabetes[J]. Diabetes,2001,50:1134-1142.
[21] Arsenijevic D , Onnma H , Pecqueur C , et al. Distruption of uncouplingprotein22 gene in mice reveals a role in immunity and reactive oxygenspecies production[J]. Nat Genet ,2000,26:435-439.
[22] Garcia-Martinez C, Sibille B, Solanes G, et al. Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation [J]. FASEB J,2001,Sep 15(11): 2033-2035.
[23] Uve dressel, Tamara L. Allen, Jyotsna B. pippal.et al. The peroxisome proliferator-activated receptor _/_agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells[J]. Mol Endocrinol,2003,17(12):2477-2493.
[2]Mauro A.Satellite cells of skeletal muscle fibers[J].J Biophys Biochem Cytol,1961,9:493-495.
[3]Gibson MC,Schultz E.Age2related differences in absolute numbers of skeletal muscle satellite cell s[J].Muscle Nerve,1983,6(8):574-580.
[4]吕捷,赵春礼,鲁强,等.成年动物骨骼肌细胞原代培养及转染外源基因的初步研究[J].解剖学报,2000,31(1):87-89.
[5]Allen RE,Temm - Grove CJ,Sheehan SM,et al.Skeletal muscle satellite cell cultures[J].Methods Cell Bio,1997,52:155-176.
[6]周菲,秦永文,荆清,等.成年大鼠肌卫星细胞的原代培养[J]。中华老年心脑血管病杂志,2001,3(1):344-346.
[7]Bonavaud S,Agbulut O,D'Honneur G,et al.Preparation of isolated human muscle fibers:a technical report[J].In Vitro Cell Dev Biol Anim,2002,38(2):66-72.
[8]黄汉伟,徐建光,顾玉东,等.人体肌卫星细胞培养的实验研究[J].中国修复重建外科杂志,2001,15(5):265-268.
[9]邵素霞,张雷,赵春芳,等.新生大鼠骨骼肌卫星细胞的原代培养及标记方法[J].基础医学与临床,2004,24(1):79-82.
[11]李志华,宋锦,李小玉,等.SD大鼠乳鼠咀嚼肌肌卫星细胞的原代培养[J].江西医学院学报,2005,45(1):17-19.
[10]陈岩,王琨,朱大海.鸡骨骼肌卫星细胞的分离培养、鉴定及生物学特性研究[J],遗传,2006,28(3):257-260.
[12]杨成、周树夏.肌肉组织工程的基础研究-不同培养条件对卫星细胞增殖的影响[J].中国美容医学,2004,13(2),135-137.
[13]魏宽海,裴国献,史宇恒,等.骨骼肌卫星细胞的培养鉴定及生物学特性[J].中国危重病急救医学,2002,14(2):10.
[1]Kenneth J,Livak,Thomas D,Schmittgen,et al.Analysis of relative gene expression data using real-time quantitative PCR and the 2~(-△△Ct)Ct method.Methods 25,2001,402-408.
[2]HEID CA,SREVRNS J.Real time quantitative PCR[J].Genome Research,1996,6:986-994.
[3]BECKER K,PAN D,WHITELYCB.Real-time quantitative polymerase chain reaction to assess gene transfer[J].Hum Gene The,1999,10:2559-2566.
[4]Whitcombe D,Brownie J,Gillard HL,et al.A homegenenous fluorescence assay for PCR amplicons:its application to real-time,single-tube genotyping[J].Clin Chem,1998,44(4):918-923.
[5]Chiang P-W,Song W-J,Wu K-Y,et al.Use of a fluorescent PCR reaction to detect genomic sequence copy number and transcription abundance[J].Genome Res,1996,6(2):1013-1026.
[6]李秀钧.胰岛素抵抗综合征.北京:人民卫生出版社,2001,123:108-110.
[7]Stuart CA,Wen G,Williamson ME,et al.Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4:protein in muscle from patient swith acanthosis nigricans and severe insulin resistance[J].Metabolism,2001,50(7):771-777.
[8]Blaak EE,Wolffen buttel BH,Saris WH,et al.Weight reduction and the impaired plasma derived free fatty acidoxidation in type 2 diabetes[J].Clin Endocrinol Metab,2001,86(4):1638-646
[9]林媛媛,蒙碧辉.游离脂肪酸异常蓄积与骨骼肌胰岛素抵抗[J].广西医科大学学报,2006,Aug,23(4):683-685.
[10]高磊,鲍羿,洪斌.B类清道夫受体CD36的研究进展[J].医学分子生物学杂志,2006,3(1):61-64.
[11]POHL J,R INGA,EHEHALT R,et all Long2chain fatty acid up take into adipocytes depends on lip id raft function[J].Biochemistry,2004,43(14):4179-4187.
[12]Bonen A,Benton CR,Campbell SE et al.Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction,insulin and leptin,and in obesity and diabetes[J].Acta Physiol Scand,2003,178:347-356.
[13]J.J.Luiken,D.J.Dyck,X.X.Han,et al.Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane[J].Am.J.Physiol:Endocrinol.Metab,2002,282:E491-E495.
[14]Arend Bonen,Michelle L.Parolin,Gregory R.Steinberg.Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36[J].The FASEB Journal,2004,10:1065-1096.
[15]Sampson MJ,Davies IR,et al.Increased expression of a scavenger receptor CD36 in monocytes from subjects with type 2 diabetes[J].Atherosclerosis,2003,167:129-134.
[16]Michael JS,Isabel RD,Simon B,et al.Increased expression of a scavenger receptor(CD36)in monocytes from subjects with type 2 diabetes[J].Atherosclerosis,2003,167:129-134.
[17]贾维娜,宋光耀.游离脂肪酸对骨骼肌葡萄糖利用的影响[J].国外医学内科学分册,2006,33(12):532-535.
[18]杨光锐,吴静,陈丽红.代谢性核受体及其与代谢综合征的关系[J].基础医学与临床.2006,26(1):35-41.
[19]Hubertina M.lmsen,Theodore P,Ciaraldi,et al.Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J].Am J Physiol Endocrinol Metab,2003,285:E354-E362.
[20] George E. O. Muscat Brandee L. Wagner, Jinzhao Hou, et al. Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors[J]. The Journal of Biological Chemistry,2002,277:40722-40728.
[21] FEBBRA IO M, HAJJAR D P, SILVERSTEINRL. CD36: a class B scavenger recep tor involved in angiogenesis, atherosclerosis, inflammation, and lip id metabolism[J]. J Clin Invest, 2001,108 (6) : 785-791.
[22] Hubertina M.lmsen, Theodore P. Ciaraldi, Leslie Carter,et al.Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J]. Am J Physiol Endocrinol Metab,2003,285: E354-E362.
[23] CH INETTI G, LESTAVEL S, BOCHER V, et al. PPAR-alpha and PPAR2gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway[J]. NatMed, 2001,7 (1): 53-58
[24] Eili T. Kase, Andreas J. Wensaas.Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway[J]. Diabetes, 2005, 54: 1108-1115.
[25] Sean B. Joseph, Bryan A. Laffitte, Parthive H. Patel, et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors[J].The Journal of Biological Chemistry, 2002,277:11019-11025.
[1]Hironobu Makino,Hiroaki Shimizu,Hiroshi Ito,et al.Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy.World J Gastroenteol,2006April,7;12(13):2053-2059.
[2]Kenneth J,Livak,Thomas D,Schmittgen,et al.Analysis of relative gene expression data using real-time quantitative PCR and the 2~(-△△Ct)Ct method.Methods 25,2001,402-408.
[3]IBrahimi A,Bonen A,Blinn WD,et al.Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscles,reduces plasma triglycerides and fatty acids,and increases plasma glucose and insulin[J].Journal of Biological Chemistry,1999,274,26761-26766.
[4] Rutter GA ,Da Silva Xavier G,Leclerc I. Roles of 5'AMP-activated protein kinase in mammalian glucose homeostasis[J].BiochemJ,2003,375:1216-1219.
[5] Tsuboi T ,Da Silva Xavier G,Leclerc I ,et al. 5'2 AMP activated protein kinase controls insulin2containing secretory vesicle dynamics[J]. J Biol Chem,2003,278:52042-52051.
[6] Wu J,Zhang Y,Wang N, et al.Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells [J] .Am J Physiol Renal Physiol ,2004,287:F886-895.
[7] Da Silva Xavier QLeclerc I,Varadi A,et al.Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression[J].BiochemJ, 2003,371:761-774.
[1]E.Corpeleijn,C.J.H.van der Kallen,et al.Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance[J].2006,Diabetic Medicine,23,907-911.
[2]Tanaka T,Nakata T,et al.Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations[J].Lipid Res,2001,42:751-759.
[3]林媛媛,蒙碧辉.游离脂肪酸异常蓄积与骨骼肌胰岛素抵抗[J].广西医科大学学报,2006,23(4):683-685.
[4]贾维娜,宋光耀.游离脂肪酸对骨骼肌葡萄糖利用的影响[J].国外医学内科学分册,2006,33(12):532-535.
[5]Veronic Bezairel,Clinton R.Brucel,George J.F.Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes:essential role in fatty acid oxidation[J].PresS.Am J Physiol Endocrinol Metab,2006,290(3):E509-515.
[6]J.J.Luiken,D.J.Dyck,X.X.Han,et al.Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane[J].Am.J.Physiol:Endocrinol.Metab,2002,282:E491-E495.
[7]Hubertina M.Wilmsen,Theodore P.Ciaraldi,Leslie Carter,et al.Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J].Am J Physiol Endocrinol Metab,2003,28.5:E354-E362.
[1]高磊,鲍羿,洪斌.B类清道夫受体CD36的研究进展[J].医学分子生物学杂志,2006,3(1):61-64.
[2]Veronic Bezaire1,Clinton R.Bruce1,George J.F.Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes:essential role in fatty acid oxidation[J].PresS.Am J Physiol Endocrinol Metab,2006,290(3):E509-15.
[3]G.Campbell,S.E.Gordon,C.L.Carlson.et al..Differential global gene expression in red and white skeletal muscle[J].Am J Physiol Cell Physiol,2001,280:C763-C768.
[4]IBrahimi A,Bonen A,Blinn WD,et al.Muscle-specific overexpression of FAT/CD36enhances fatty acid oxidation by contracting muscles,reduces plasma triglycerides and fatty acids,and increases plasma glucose and insulin[J].Journal of Biological Chemistry,1999,274,26761-26766.
[5]Bonen,A.,Luiken,J.J.,Arumugam,Y.,et al.Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase[J].Biol.Chem,2000,275,14501-14508.
[6]Palanivel R and Sweeney G.Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin[J].FEBS Lett,2005,579:5049-5054.
[7]Turcotte LP,Raney MA and Todd MK.ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle[J].Acta Physiol Scand,2005,184:131-139.
[8]J.J.Luiken,D.J.Dyck,X.X.Han,et al.Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane[J].Am.J.Physiol:Endocrinol.Metab,2002,282:E491-E495.
[9]Arend Bonen,Michelle L.Parolin,Gregory R.Steinberg.Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36[J]. The FASEB Journal,2004,10: 1065-1096.
[10] Hubertina M.lmsen, Theodore P. Ciaraldi, Leslie Carter,et al.Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects[J]. Am J Physiol Endocrinol Metab,2003,285: E354-E362.
[11] B. Cheatham, C.R. Kahn. Insulin action and the insulin signaling network[J].Endocr. Rev, 1995,16:117-142.
[12] Steinberg, G. R., and Dyck, D. J. Development of leptin resistance in rat soleus muscle in response to high-fat diets[J]Am. J. Physiol,2000,279: E1374-E1382.
[13] Gregory R. Steinberg, David J. Dyck, Jorges Calles-Escandon.Chronic Leptin Administration Decreases Fatty Acid Uptake and Fatty Acid Transporters in Rat Skeletal Muscle[J]. The journal of biological chemistry,2002,277 (11) .8854-8860.
[14] Pohl, J., A. Ring, and W. Stremmel. Uptake of long-chain fatty acids in HepG2 cells involves caveolae: analysis of a novel pathway[J]. Lipid Res,2002,43:1390-1399.
[15] Bodil Vistisen, Kirstine Roepstorff, Carsten Roepstorff.Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers[J]. Journal of Lipid Research,2004,45:603-609.
[16] Veronic Bezaire, Clinton R. Bruce, George J. F. Heigenhauser, Narendra N. Tandon. Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes:essential role in fatty acid oxidation[J]. Am J Physiol Endocrinol Metab.2006,290: E509-E515.
[17] Shannon E. Campbell, Narendra N. Tandon, Gebretateos Woldegiorgis.A novel function for fatty acid translocase (FAT)/CD36 Involvement in long chain fatty acid transfer into the mitochondria[J]. The journal of biological chemistry,2004,279 (35) :36235-36241.
[1]朱锋,李红.LXRs与糖尿病[J].国际内分泌代谢杂志,2006,26:43-53.
[2]George E.O.Muscat Brandee L.Wagner,Jinzhao Hou,et al.Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors[J].The Journal of Biological Chemistry,2002,277:40722-40728.
[3]杨光锐,吴静,陈丽红,管又飞.代谢性核受体及其与代谢综合征的关系[J].基础医学与临床,2006,26:35-37.
[4]Horton,J.D.,J.L.Goldstein,and M.S.Brown.SREBPs:activators of the complete program of cholesterol and fatty acid synthesis in the liver[J].J.Clin.Invest,2002,109:1125-1131.
[5]Schultz JR,Tu H,Luk A,et al.Role of LXRs in control of lipogenesis[J].Genes Dev,2000,14:2831-2838.
[6]Chen,G.,G.Liang,J.Ofu,J.L.Goldstein,et al.Central role for liver X receptor in insulin-mediated activation of SREBP-1c transcription and stimulation of fatty acid synthesis in liver[J].Proc.Natl.Acad.Sci,2004,101:11245-11250.
[7]唐韬,李燕.固醇调节元件结合蛋白与脂质代谢[J].生理科学进展,2005,36:29-34.
[8]Kim,H.J.,M.Takahashi,and O.Ezaki.Fish oil feeding decreasesmature sterol regulatory element-binding protein 1(SREBP-1)by downregulationof SREBP-1c mRNA in mouse liver.A possible mechanism fordown-regulation of lipogenic enzyme mRNAs[J].Biol.Chem,1999,274:25892-25898.
[9]Eili T.Kase,Andreas J.Wensaas.Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway[J].Diabetes,2005,54:1108-1115.
[10]Ronnett.Kim EK,Landree LE Tu Y.Fatty acid metabolism as a target for obesity treatment[J].Physiol Behav,2005,85(1):25-35.
[11]Pender C,Trentadue AR,Pories WJ,et al.Expression of genes regulating Malonyl-CoA in human skeletal muscle[J].JCell Biochem,2006,99(3):860-867.
[12]Maria-Jesus Latasa,Yang Soo Moon,Kee-Hong Kim,et al.Nutritional regulation of the fatty acid synthase promoter in vivo:Sterol regulatory element binding protein functions through an upstream region containing a sterol regulatory element[J].PNAS,Sep 2000,97:10619-10623.
[13]Sean B.Joseph,Bryan A.Laffitte,Parthive H.Patel,et al.Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors[J].The Journal of Biological Chemistry,.2002,277:11019-11025.
[14]D.Cozzone.C.Debard.N.Dif.N.Ricard.E.Disse.Activation of liver X receptors promotes lipid aeeumulation but does not alter insulin action in human skeletal muscle cells[J].Diabetologia,2006,49:990-999.
[15].Luiken,J.J.,Turcotte,L.P.and Bonen,A.Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles[J].Lipid.Res,1999,40:1007-1016.
[16]Gurnell M:PPARgamma and metabolism:insights from the study of human genetic variants [J].Clin Endocrinol(Oxf),2003,59:267-277.
[17]Hulver MW,Berggren JR,Carper MJ,Miyazaki.Elevated stearoyl-CoA desaturase-l expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans[J].Cell Metab,2005,2(5):275-276.
[18] Chu K,Miyazaki M,Man WC,Ntambi JM. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation[J].Mol Cell Biol,2006,26(18):6786-6798.
[19] Dalen KT, Ulven SM, Bamberg K, et al. Expression of the insulin responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor[J]. J Biol Chem,2003, 278:48283-48291.
[20] Ducluzeau PH, Perretti N, Laville M, et al.Regulation by insulin of gene expression in human skeletal muscle and adipose tissue: evidence for specific defects in type 2 diabetes[J]. Diabetes,2001,50:1134-1142.
[21] Arsenijevic D , Onnma H , Pecqueur C , et al. Distruption of uncouplingprotein22 gene in mice reveals a role in immunity and reactive oxygenspecies production[J]. Nat Genet ,2000,26:435-439.
[22] Garcia-Martinez C, Sibille B, Solanes G, et al. Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation [J]. FASEB J,2001,Sep 15(11): 2033-2035.
[23] Uve dressel, Tamara L. Allen, Jyotsna B. pippal.et al. The peroxisome proliferator-activated receptor _/_agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells[J]. Mol Endocrinol,2003,17(12):2477-2493.